1-5 of 5
Jiří Mayer
Close
Sort by
Journal Articles

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes

Maria Agustina Perusini, Daniela Žáčková, Taehyung Kim, Katia Pagnano, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Jaeyoon Kim, Youngseok Yoo, Seongyoon Yi, Hyewon Lee, Kyoung Ha Kim, Myunghee Chang, Jose-Mario Capo-Chichi, Jessie J. F. Medeiros, Andrea Arruda, Mark Minden, Zhaolei Zhang, Sagi Abelson, Jiri Mayer, Dennis Dong Hwan Kim
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2361–2372.
https://doi.org/10.1182/bloodadvances.2023012127
Published: 2024
Includes: Supplemental data
Journal Articles

Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia

Clinical Trials & Observations
David J. Kuter, Jiri Mayer, Merlin Efraim, Lachezar H. Bogdanov, Ross Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Y. Choi, A. J. Gerard Jansen, Vickie McDonald, Robert Bird, Jaromir Gumulec, Milan Kostal, Terry Gernsheimer, Waleed Ghanima, Ahmed Daak, Nichola Cooper
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1715–1724.
https://doi.org/10.1182/bloodadvances.2023012044
Published: 2024
Includes: Supplemental data
Journal Articles

Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study

Clinical Trials & Observations
Pierre Fenaux, Marco Gobbi, Patricia L. Kropf, Jean-Pierre J. Issa, Gail J. Roboz, Jiri Mayer, Jürgen Krauter, Tadeusz Robak, Hagop Kantarjian, Jan Novak, Wieslaw. W. Jedrzejczak, Xavier Thomas, Mario Ojeda-Uribe, Yasushi Miyazaki, Yoo Hong Min, Su-Peng Yeh, Joseph Brandwein, Liana Gercheva-Kyuchukova, Judit Demeter, Elizabeth Griffiths, Karen Yee, Konstanze Döhner, Yong Hao, Harold Keer, Mohammad Azab, Hartmut Döhner
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5027–5037.
https://doi.org/10.1182/bloodadvances.2023010179
Published: 2023
Includes: Supplemental data
Journal Articles

Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials

Clinical Trials & Observations
Srdan Verstovsek, Ruben Mesa, Vikas Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T. Oh, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Aaron Gerds, Miklos Egyed, Jiří Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire Harrison
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3582–3591.
https://doi.org/10.1182/bloodadvances.2022009311
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

Clinical Trials & Observations
Sebastian Stasik, Jan-Niklas Eckardt, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede, on behalf of the Study Alliance Leukemia (SAL)
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3279–3289.
https://doi.org/10.1182/bloodadvances.2021004631
Published: 2021
Includes: Supplemental data